Growing Medicare costs had already set the stage for Medicare Advantage (MA) growth long before the COVID-19-induced economic downturn. Now, the pandemic is likely to further accelerate that growth trajectory. In this week’s episode, Sg2’s Senior Advisor on health policy, Valinda Rutledge, and our resident MA expert, Trevor DaRin, discuss the market conditions and model dynamics that support a bright future for Medicare Advantage.